Artwork

Content provided by Kym McNicholas. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Kym McNicholas or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Weight Loss Drug Reduces Leg Cramps In Diabetics With PAD

47:56
 
Share
 

Manage episode 475299526 series 1374780
Content provided by Kym McNicholas. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Kym McNicholas or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

For the first time in over TWO DECADES, there's a new medication treatment approach for peripheral artery disease!

The groundbreaking STRIDE Trial has shown that semaglutide significantly improves walking ability and quality of life for those suffering from PAD with type 2 diabetes. JOIN US THURSDAY as we interview Dr. Marc Bonaca, co-investigator of this landmark study that revealed: ✅ 40-meter improvement in walking distance ✅ Significant quality of life benefits ✅ 54% reduction in disease progression requiring intervention ✅ Benefits potentially extending beyond weight loss This could be life-changing for millions who struggle with leg pain that limits everyday activities. Have questions about what this means for your PAD treatment? Drop them below and Dr. Bonaca will address them during our exclusive interview! #PADBreakthrough #DiabetesCare #STRIDETrial #PatientVoices #MedicalAdvancement #semaglutitude #ozempic #ozempicwalking #wegovywalking #wegovysupport #markbonaca #globalpadassociation #peripheralarterydisease #peripheralarterydiseasetreatment #claudicationcure
  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 475299526 series 1374780
Content provided by Kym McNicholas. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Kym McNicholas or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

For the first time in over TWO DECADES, there's a new medication treatment approach for peripheral artery disease!

The groundbreaking STRIDE Trial has shown that semaglutide significantly improves walking ability and quality of life for those suffering from PAD with type 2 diabetes. JOIN US THURSDAY as we interview Dr. Marc Bonaca, co-investigator of this landmark study that revealed: ✅ 40-meter improvement in walking distance ✅ Significant quality of life benefits ✅ 54% reduction in disease progression requiring intervention ✅ Benefits potentially extending beyond weight loss This could be life-changing for millions who struggle with leg pain that limits everyday activities. Have questions about what this means for your PAD treatment? Drop them below and Dr. Bonaca will address them during our exclusive interview! #PADBreakthrough #DiabetesCare #STRIDETrial #PatientVoices #MedicalAdvancement #semaglutitude #ozempic #ozempicwalking #wegovywalking #wegovysupport #markbonaca #globalpadassociation #peripheralarterydisease #peripheralarterydiseasetreatment #claudicationcure
  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play